The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 85 (2) , 174-185
- https://doi.org/10.1016/s0022-5223(19)38872-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Results of a survey of the professional activities of 811 cardiopulmonary perfusionistsThe Journal of Thoracic and Cardiovascular Surgery, 1982
- Heparin kinetics: Variables related to disposition and dosageClinical Pharmacology & Therapeutics, 1981
- Monitoring Heparin Anticoagulation and Its NeutralizationThe Annals of Thoracic Surgery, 1981
- Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary BypassAnnals of Surgery, 1981
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- Plasma Heparin Activity and Antagonism During Cardiopulmonary Bypass with HypothermiaAnesthesia & Analgesia, 1977
- Is Protamine a Clinically Important Anticoagulant?Anesthesiology, 1971
- Problems In Hemostasis During Open Heart SurgeryAnnals of Surgery, 1967
- Activated Coagulation Time of Whole BloodJAMA, 1966
- Bleeding after Perfusion for Open Heart SurgeryBMJ, 1960